(PLUS) ePlus - Overview
Stock: Hardware, Software, Maintenance, Financing, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.63% |
| Yield on Cost 5y | 1.08% |
| Yield CAGR 5y | % |
| Payout Consistency | 10.0% |
| Payout Ratio | 12.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.0% |
| Relative Tail Risk | -13.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.21 |
| Alpha | -7.33 |
| Character TTM | |
|---|---|
| Beta | 0.960 |
| Beta Downside | 0.665 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.13% |
| CAGR/Max DD | 0.31 |
Description: PLUS ePlus January 16, 2026
ePlus inc. (NASDAQ:PLUS) delivers a broad portfolio of IT solutions-including third-party hardware, software (perpetual and subscription), and managed services-to enterprise customers across telecom, media, technology, government, education, healthcare, and financial services.
Beyond product resale, the firm generates recurring revenue through lifecycle-services support, cloud-managed offerings (e.g., Azure Recovery, Storage-as-a-Service), and security-as-a-service, while also providing financing structures such as sales-type leases, consumption-based financing, and asset disposal.
Key financial indicators (FY 2023) show revenue of roughly **$1.5 billion**, with **~12 %** of sales derived from subscription-based and managed-service contracts-an area that has been expanding at **~15 % YoY**, reflecting broader enterprise migration to cloud and “as-a-service” models.
Sector drivers include sustained growth in U.S. IT spending (projected CAGR ~5 % through 2027) and heightened demand for digital-signage, EV-charging infrastructure, and security solutions-segments where ePlus has positioned dedicated practice groups.
Operating margins have been pressured by inventory and logistics costs, but the company’s **asset-light financing model** helps mitigate capital intensity and supports higher return on invested capital relative to traditional distributors.
For a deeper quantitative view, the ValueRay platform provides granular financial and operational metrics for PLUS.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 121.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -13.12 > 1.0 |
| NWC/Revenue: 33.02% < 20% (prev 26.40%; Δ 6.62% < -1%) |
| CFO/TA 0.05 > 3% & CFO 92.9m > Net Income 121.9m |
| Net Debt (-303.6m) to EBITDA (189.5m): -1.60 < 3 |
| Current Ratio: 2.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.4m) vs 12m ago -1.01% < -2% |
| Gross Margin: 26.07% > 18% (prev 0.25%; Δ 2582 % > 0.5%) |
| Asset Turnover: 130.1% > 50% (prev 123.1%; Δ 7.01% > 0%) |
| Interest Coverage Ratio: 145.1 > 6 (EBITDA TTM 189.5m / Interest Expense TTM 1.09m) |
Altman Z'' 6.41
| A: 0.42 (Total Current Assets 1.37b - Total Current Liabilities 628.1m) / Total Assets 1.77b |
| B: 0.52 (Retained Earnings 916.9m / Total Assets 1.77b) |
| C: 0.09 (EBIT TTM 158.0m / Avg Total Assets 1.73b) |
| D: 1.28 (Book Value of Equity 922.5m / Total Liabilities 720.7m) |
| Altman-Z'' Score: 6.41 = AAA |
Beneish M -3.36
| DSRI: 0.78 (Receivables 676.8m/800.5m, Revenue 2.26b/2.09b) |
| GMI: 0.94 (GM 26.07% / 24.57%) |
| AQI: 0.70 (AQ_t 0.16 / AQ_t-1 0.23) |
| SGI: 1.08 (Revenue 2.26b / 2.09b) |
| TATA: 0.02 (NI 121.9m - CFO 92.9m) / TA 1.77b) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
What is the price of PLUS shares?
Over the past week, the price has changed by -0.18%, over one month by -2.13%, over three months by +14.61% and over the past year by +5.26%.
Is PLUS a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PLUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 92 | 8.7% |
| Analysts Target Price | 92 | 8.7% |
| ValueRay Target Price | 93 | 9.8% |
PLUS Fundamental Data Overview February 03, 2026
P/E Forward = 18.622
P/S = 0.9995
P/B = 2.1435
P/EG = 1.8639
Revenue TTM = 2.26b USD
EBIT TTM = 158.0m USD
EBITDA TTM = 189.5m USD
Long Term Debt = 11.3m USD (from longTermDebt, last fiscal year)
Short Term Debt = 98.5m USD (from shortTermDebt, last quarter)
Debt = 98.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -303.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.98b USD (2.28b + Debt 98.5m - CCE 402.2m)
Interest Coverage Ratio = 145.1 (Ebit TTM 158.0m / Interest Expense TTM 1.09m)
EV/FCF = 22.58x (Enterprise Value 1.98b / FCF TTM 87.7m)
FCF Yield = 4.43% (FCF TTM 87.7m / Enterprise Value 1.98b)
FCF Margin = 3.89% (FCF TTM 87.7m / Revenue TTM 2.26b)
Net Margin = 5.40% (Net Income TTM 121.9m / Revenue TTM 2.26b)
Gross Margin = 26.07% ((Revenue TTM 2.26b - Cost of Revenue TTM 1.67b) / Revenue TTM)
Gross Margin QoQ = 26.63% (prev 23.26%)
Tobins Q-Ratio = 1.12 (Enterprise Value 1.98b / Total Assets 1.77b)
Interest Expense / Debt = 0.58% (Interest Expense 572.0k / Debt 98.5m)
Taxrate = 29.33% (15.8m / 54.0m)
NOPAT = 111.7m (EBIT 158.0m * (1 - 29.33%))
Current Ratio = 2.19 (Total Current Assets 1.37b / Total Current Liabilities 628.1m)
Debt / Equity = 0.09 (Debt 98.5m / totalStockholderEquity, last quarter 1.05b)
Debt / EBITDA = -1.60 (Net Debt -303.6m / EBITDA 189.5m)
Debt / FCF = -3.46 (Net Debt -303.6m / FCF TTM 87.7m)
Total Stockholder Equity = 1.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.03% (Net Income 121.9m / Total Assets 1.77b)
RoE = 12.17% (Net Income TTM 121.9m / Total Stockholder Equity 1.00b)
RoCE = 15.60% (EBIT 158.0m / Capital Employed (Equity 1.00b + L.T.Debt 11.3m))
RoIC = 9.90% (NOPAT 111.7m / Invested Capital 1.13b)
WACC = 9.08% (E(2.28b)/V(2.38b) * Re(9.45%) + D(98.5m)/V(2.38b) * Rd(0.58%) * (1-Tc(0.29)))
Discount Rate = 9.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.55%
[DCF Debug] Terminal Value 65.50% ; FCFF base≈175.6m ; Y1≈115.3m ; Y5≈52.6m
Fair Price DCF = 44.26 (EV 866.6m - Net Debt -303.6m = Equity 1.17b / Shares 26.4m; r=9.08% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -32.04 | EPS CAGR: -44.79% | SUE: -3.27 | # QB: 0
Revenue Correlation: 48.14 | Revenue CAGR: 5.68% | SUE: 1.35 | # QB: 2
EPS next Year (2027-03-31): EPS=4.96 | Chg30d=+0.435 | Revisions Net=+1 | Growth EPS=+10.6% | Growth Revenue=+0.6%